Systemic phosphate pool

The systemic phosphate pool represents the total amount of inorganic phosphorus available in the extracellular fluid, intracellular compartments, and mineralized bone (StatPearls, 2023). Phosphorus is a critical element for life, serving as a structural component of DNA, RNA, and cell membranes, and playing a central role in energy metabolism through ATP (NIH, 2023). Systemic levels are tightly regulated by a complex interplay between intestinal absorption, renal excretion, and bone remodeling, primarily controlled by hormones such as parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and active vitamin D (Journal of Clinical Investigation, 2006). Dysregulation of this pool leads to clinical conditions like hyperphosphatemia, which is common in chronic kidney disease and contributes to cardiovascular calcification, or hypophosphatemia, seen in genetic disorders like X-linked hypophosphatemia (Nature Reviews Nephrology, 2022). While the pool itself is not a single molecular target, various drugs like phosphate binders, FGF23 antibodies (e.g., Burosumab), and vitamin D analogs are used to modulate its levels to treat metabolic bone diseases and mineral disorders (PubMed, 2021).

Other names

Systemic phosphate pool / general cellular phosphorus utilizationPhosphorus homeostasisSerum inorganic phosphatePhosphate metabolismCellular phosphorus utilization

Therapeutic agents modulate the systemic phosphate pool by binding dietary phosphate in the gastrointestinal tract to prevent absorption, inhibiting renal phosphate reabsorption via sodium-phosphate cotransporters, or neutralizing phosphaturic hormones like FGF23.